ICON is an Ireland-based contract research firm that provides services such as drug development and clinical research for sectors including pharmaceutical and biotechnology.
Read moreAnnual Revenue
$6.5B
ICON's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 3.5B. Over the last four quarters, ICON's revenue has grown by 118.3%. Specifically, in Q1 2022's revenue was $1.9B; in Q4 2021, it was $1.9B; in Q3 2021, it was $1.9B; in Q2 2021, ICON's revenue was $871.2M.